Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
Holmes FA, Madden T, Newman RA, Valero V, Theriault RL, Fraschini G, Walters RS, Booser DJ, Buzdar AU, Willey J, Hortobagyi GN. Holmes FA, et al. Among authors: hortobagyi gn. J Clin Oncol. 1996 Oct;14(10):2713-21. doi: 10.1200/JCO.1996.14.10.2713. J Clin Oncol. 1996. PMID: 8874332 Clinical Trial.
Current management of advanced breast cancer.
Hortobagyi GN, Piccart-Gebhart MJ. Hortobagyi GN, et al. Semin Oncol. 1996 Oct;23(5 Suppl 11):1-5. Semin Oncol. 1996. PMID: 8893891 Review. No abstract available.
Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group.
Theriault RL, Lipton A, Hortobagyi GN, Leff R, Glück S, Stewart JF, Costello S, Kennedy I, Simeone J, Seaman JJ, Knight RD, Mellars K, Heffernan M, Reitsma DJ. Theriault RL, et al. Among authors: hortobagyi gn. J Clin Oncol. 1999 Mar;17(3):846-54. doi: 10.1200/JCO.1999.17.3.846. J Clin Oncol. 1999. PMID: 10071275 Clinical Trial.
Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: hortobagyi gn. J Clin Oncol. 1999 Feb;17(2):460-9. doi: 10.1200/JCO.1999.17.2.460. J Clin Oncol. 1999. PMID: 10080586 Clinical Trial.
1,102 results